Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/04/2010 | US20100278775 Plant Bioreactor For The Production Of Interleukin-24 Cytokine |
11/04/2010 | US20100278774 Fusion molecules and il-15 variants |
11/04/2010 | US20100278768 Compounds and Methods for Inhibiting Axillary Malodour |
11/04/2010 | US20100275502 Rodenticide |
11/04/2010 | CA2759911A1 Protein electron mediator |
11/04/2010 | CA2759370A1 Method for the production of domain antibodies |
11/03/2010 | EP2246430A1 Anti-adam-15 antibodies and utilization of the same |
11/03/2010 | EP2246428A1 Modified trna containing non-natural nucleotide and use thereof |
11/03/2010 | EP2246427A1 Antibody capable of binding specifically to a -oligomer, and use thereof |
11/03/2010 | EP2246426A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
11/03/2010 | EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/03/2010 | EP2245173A2 Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
11/03/2010 | EP2245160A1 Cell surface display of proteins |
11/03/2010 | EP2245156A1 Humanized anti- 9 integrin antibodies and the uses thereof |
11/03/2010 | EP2245145A2 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
11/03/2010 | EP2245137A1 Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
11/03/2010 | EP1674111B1 Anti-glypican 3 antibody |
11/03/2010 | EP1602720B1 Process for producing heterologous protein in e. coli |
11/03/2010 | EP1583512B1 USE of LIGNIN PEROXIDASE IN SKIN AND HAIR LIGHTENING |
11/03/2010 | EP1261718B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
11/03/2010 | EP1076662B1 Polyepitope carrier protein |
11/03/2010 | EP1064019B1 Chemically modified mutant enzymes and methods for producing them and screening them |
11/03/2010 | EP0568575B2 Test and model for alzheimer's disease |
11/03/2010 | CN1368888B Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
11/03/2010 | CN101878302A Pseudomonas aeruginosa outer membrane protein PA4710 |
11/03/2010 | CN101878301A Antibody and use thereof |
11/03/2010 | CN101875958A Method for improving glutathione content in selenium-enriched Candida utilis |
11/03/2010 | CN101875957A Chinese hamster apoptosis-related genes |
11/03/2010 | CN101875956A Hair-care coix seed polypeptide and preparation method thereof |
11/03/2010 | CN101875699A Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof |
11/03/2010 | CN101875692A Chinese hamster apoptosis-related genes |
11/03/2010 | CN101555479B Moss expressing promoting regions |
11/03/2010 | CN101353688B Preparation and use of kudzu root peptides |
11/02/2010 | US7825228 Bone mineralization proteins, DNA, vectors, expression systems |
11/02/2010 | US7825227 Method for purification of a protein complex and identification of its components |
11/02/2010 | US7825226 Pharmacokinetics; glycosyltransferases |
11/02/2010 | US7825225 Vaccine |
11/02/2010 | US7825221 Hepatocyte growth factor activator specific monoclonal antibody for treatment and prevention of proliferation, migration and angiogenesis of tumor cells |
11/02/2010 | US7825218 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
11/02/2010 | US7824895 Phytases, nucleic acids encoding them and methods for making and using them |
11/02/2010 | US7824893 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
11/02/2010 | US7824891 Method for producing D-pantothenic acid and/or salts thereof via purification by electrodialysis as an additive for animal feed |
11/02/2010 | US7824885 Expression vector comprising pro-subtilisin nucleotide sequences for use as drug delivery system in gene therapy |
11/02/2010 | US7824884 Genetically engineered glucanase for conversion of cellulosic feedstocks into ethanol; renewable energy; clean energy; green power; improving detergents and textile processing |
11/02/2010 | US7824692 homologous immunoreactive thio-disulfide oxidoreductases; fusion proteins; fluorescent, radioactive, or enzymatic labels |
11/02/2010 | US7824683 Methods for augmenting an immune response using anti-CD40 antibodies |
11/02/2010 | US7824677 inhibiting blood coagulation mediated by factor X binding to tissue factor; provide superior anti-coagulant activity by binding native human tissue factor with high affinity and specificity; linked covalently to a cell antigen or an effector molecule to provide complement fixing ability |
11/02/2010 | CA2621088C Genetically engineered fowlpox-based vaccine strain |
11/02/2010 | CA2487673C Improved method for the recombinant production and purification of protein kinases |
11/02/2010 | CA2454731C A system for antibody expression and assembly |
11/02/2010 | CA2253246C Purified multimerase |
11/02/2010 | CA2181394C Ctla4 mutant molecules and uses thereof |
11/02/2010 | CA2150555C Cloning and expression of biologically active alpha-galactosidase a |
11/02/2010 | CA1341608C Promoters of filamentous fungi and use thereof |
11/02/2010 | CA1341607C Production of erythropoietin |
10/28/2010 | WO2010123994A1 Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof |
10/28/2010 | WO2010123561A1 Antibodies specific to e6 proteins of hpv and use thereof |
10/28/2010 | WO2010123080A1 Method for producing soluble sr-a protein and evaluation method using same |
10/28/2010 | WO2010123014A1 Method for preparing cell highly producing heterogeneous protein |
10/28/2010 | WO2010123013A1 Tag peptide having protease recognition sequence and utilization of same |
10/28/2010 | WO2010123012A1 Antibody containing igg2 having amino acid mutation introduced therein |
10/28/2010 | WO2010121933A1 Process for the production of a recombinant polypeptide of interest |
10/28/2010 | WO2010121818A1 Production of multi-antennary n-glycan structures in plants |
10/28/2010 | US20100273995 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds |
10/28/2010 | US20100273980 Fungal pepc inhibitor |
10/28/2010 | US20100273978 Modified polypeptides suitable for acceptace of amino acid substited molecules |
10/28/2010 | US20100273862 Phosphatases which activate map kinase pathways |
10/28/2010 | US20100273274 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
10/28/2010 | US20100273216 Methods for protein refolding |
10/28/2010 | US20100273215 Secretion Yield of a Protein of Interest by in vivo Proteolytic Processing of a Multimeric Precursor |
10/28/2010 | US20100273214 for conversion of cellulosic biomass into useful products including ethanol; biofuels |
10/28/2010 | US20100273213 Method for expression of specific gene |
10/28/2010 | US20100273212 PP1 Ligands |
10/28/2010 | US20100273211 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
10/28/2010 | US20100273202 Codon-optimized nucleic acid for coding apo-clytin-ii and method for using the same |
10/28/2010 | US20100273161 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin |
10/28/2010 | US20100272788 Vaccines for malaria |
10/28/2010 | US20100272751 Truncated l1 protein of human papillomavirus type 18 |
10/28/2010 | US20100272738 Anti-ox40l antibodies and methods using same |
10/28/2010 | US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES |
10/28/2010 | US20100272734 Compositions and methods for increasing muscle growth |
10/28/2010 | US20100272731 Engineered anti-il-23p19 antibodies |
10/28/2010 | US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof |
10/28/2010 | US20100272719 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains |
10/28/2010 | US20100272718 Antibodies Against Human NKG2D and Uses Thereof |
10/28/2010 | US20100272707 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof |
10/28/2010 | US20100272659 Recombinant preparation of selected bromelain fractions |
10/28/2010 | US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor |
10/28/2010 | CA2759276A1 Production of multi-antennary n-glycan structures in plants |
10/28/2010 | CA2759146A1 Antibody containing igg2 having amino acid mutation introduced therein |
10/28/2010 | CA2758842A1 Fgfr1c antibody combinations |
10/28/2010 | CA2758404A1 Process for the production of a recombinant polypeptide of interest |
10/27/2010 | EP2243827A1 Serum-free mammalian cell culture medium, and uses thereof |
10/27/2010 | EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
10/27/2010 | EP1840210B1 Reconstitution of 5-enolpyruvylshikimate-3-phosphate synthase activity by fragment complementation |
10/27/2010 | EP1692160B1 Fgf-5 binding and supported peptides |
10/27/2010 | EP1487877B1 Compositions and methods for the diagnosis of tumors |
10/27/2010 | EP1218509B9 Fibroblast growth factor-like polypeptides |
10/27/2010 | EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna |
10/27/2010 | CN101874042A Method of modifying isoelectric point of antibody via amino acid substitution in cdr |